Código QR

Health Services Access Inequalities in Brazil Result in Poorer Outcomes for Stage III NSCLC—RELANCE/LACOG 0118

Introduction: Stage III NSCLC is a heterogeneous disease, representing approximately one-third of newly diagnosed lung cancers. Brazil lacks detailed information regarding stage distribution, treatment patterns, survival, and prognostic variables in locally advanced NSCLC. Methods: RELANCE/LACOG 011...

ver descrição completa

Na minha lista:
Principais autores: Vladmir C. Cordeiro de Lima, MD, PhD, Ana Gelatti, MD, MSc, José F.P. Moura, MD, PhD, Aline F. Fares, MD, MSc, Gilberto de Castro, Jr., MD, PhD, Clarissa Mathias, MD, PhD, Ricardo M. Terra, MD, PhD, Gustavo Werutsky, MD, PhD, Marcelo Corassa, MD, Luiz Henrique L. Araújo, MD, PhD, Eduardo Cronenberger, MD, MSc, Fernanda K. Fujiki, MD, Sandro Reichow, MD, Antônio Vinícius T. da Silva, MD, Tércia V. Reis, MD, Mônica Luciana A. Padoan, MD, Patrícia Pacheco, MD, Rosely Yamamura, MD, Caroline Kawamura, MD, Eldsamira Mascarenhas, MD, MSc, Rafaela G. de Jesus, MSc, Gustavo Gössling, MD, Clarissa Baldotto, MD, PhD
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2024-03-01
Colecção:JTO Clinical and Research Reports
Assuntos:
NSCLC
Epidemiology
Stage III
Health insurance
Survival
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S266636432400016X
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados